13-azaprostanoic acid has been researched along with thromboxanes in 13 studies
| Studies (13-azaprostanoic acid) | Trials (13-azaprostanoic acid) | Recent Studies (post-2010) (13-azaprostanoic acid) | Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) |
|---|---|---|---|---|---|
| 42 | 0 | 0 | 3,202 | 149 | 199 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (92.31) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brace, LD; Le Breton, GC; Venton, DL | 2 |
| Hofmann, U; Leytin, VL; Misselwitz, F; Repin, VS | 1 |
| Hechtman, HB; Shepro, D; Welles, SL | 1 |
| Anderson, KS; Feller, DR; Miller, DD; Mukhopadhyay, A; Navran, SS; Romstedt, K | 1 |
| Brace, LD; Fareed, J; Issleib, S | 1 |
| Ghali, NI; Hung, SC; Le Breton, GC; Venton, DL | 1 |
| Le Breton, GC; Parise, LV; Venton, DL | 1 |
| Feinberg, H; Ho, T; Le Breton, GC; Lipowski, JP; Venton, DL; Wu, KK | 1 |
| Le Breton, GC; Rybicki, JP; Venton, DL | 1 |
| Cook, JA; Halushka, PV; Wise, WC | 1 |
| Colwell, JA; Halushka, PV; Loadholt, CB; Rogers, RC | 1 |
| Casonato, A; Deana, R; Francesconi, M; Girolami, A; Scapin, M | 1 |
13 other study(ies) available for 13-azaprostanoic acid and thromboxanes
| Article | Year |
|---|---|
Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Cyclic AMP; Epoprostenol; Humans; Ion Channels; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes | 1985 |
Influence of thromboxane receptor-antagonists on the interaction of platelets with solid-phase immobilized human collagen.
Topics: Blood Platelets; Collagen; Fatty Acids; Humans; Platelet Aggregation; Prostanoic Acids; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 1987 |
Eicosanoid modulation of stress fibers in cultured bovine aortic endothelial cells.
Topics: Actin Cytoskeleton; Animals; Aorta; Cattle; Cells, Cultured; Chromones; Cytoskeleton; Eicosanoic Acids; Endothelium; Epoprostenol; Leukotriene B4; Prostanoic Acids; Receptors, Immunologic; Surface Properties; Thromboxanes | 1985 |
Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
Topics: Adult; Animals; Blood Platelets; Dose-Response Relationship, Drug; Fatty Acids; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Antagonists; Prostanoic Acids; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes; Vasoconstriction | 1985 |
Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Epoprostenol; Humans; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes | 1985 |
Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway.
Topics: Aspirin; Bleeding Time; Heparin; Heparin Antagonists; Humans; Indomethacin; Platelet Aggregation; Prostanoic Acids; Thromboxanes | 1985 |
Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
Topics: Binding Sites; Blood Platelets; Cell Membrane; Fatty Acids; Humans; In Vitro Techniques; Kinetics; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes | 1983 |
Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Drug Interactions; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes | 1984 |
Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fatty Acids; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Rabbits; Thrombosis; Thromboxane A2; Thromboxanes | 1984 |
The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
Topics: Adenosine Triphosphate; Arachidonic Acids; Blood Platelets; Calcium; Cell Membrane; Fatty Acids; Humans; In Vitro Techniques; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Thromboxane A2; Thromboxanes | 1983 |
Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
Topics: Animals; Fatty Acids, Essential; Imidazoles; Prostanoic Acids; Rats; Shock, Septic; Thromboxane A2; Thromboxane B2; Thromboxanes | 1980 |
Increased platelet thromboxane synthesis in diabetes mellitus.
Topics: Adult; Blood Platelets; Diabetes Mellitus; Female; Humans; Imidazoles; Male; Platelet Aggregation; Prostanoic Acids; Thromboxane A2; Thromboxane B2; Thromboxanes | 1981 |
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Antagonists; Arachidonic Acid; Aspirin; Blood Platelets; Calcium; Drug Synergism; Epinephrine; Humans; Kinetics; Lipoxygenase; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostanoic Acids; Serotonin; Sympathomimetics; Thromboxanes; Tyrosine; Vasoconstrictor Agents; von Willebrand Factor; Yohimbine | 2000 |